Fig 1.
Participant recruitment and enrolment flow diagram.
Table 1.
Demographic characteristics and visible sequelae of study population (N = 197).
Fig 2.
Prevalence of disability severity among the three study groups (Controls, n = 57, SB, n = 53, and SBE, n = 87) as measured by the WHODAS 2.0.
Snakebite survivors in the SBE group had a more severe envenoming than survivors in the SB group based on history.
Fig 3.
WHODAS 2.0 domain scores among the three study groups (Controls, n = 57; SB, n = 53; SBE, n = 87).
The x-axis represents the percentage of participants reporting any degree of difficulty (>0 score) within each WHODAS 2.0 domain.
Table 2.
Distribution of residual functional limitations among snakebite survivors and controls across BUFLS activities.